ambroxol + cetirizine

ACT Syrup is a fixed-dose combination oral liquid formulation containing the mucolytic agent ambroxol and the second-generation antihistamine cetirizine. Developed and marketed by Caplet India, it is indicated for the symptomatic treatment of productive cough associated with allergic reactions and respiratory tract disorders. Cetirizine acts as a selective antagonist of peripheral histamine H1 receptors, effectively reducing allergy symptoms such as sneezing, runny nose, and itchy eyes. Ambroxol acts as a secretolytic and mucokinetic agent, thinning and loosening viscous mucus in the airways to facilitate expectoration and clear chest congestion. Together, the two active ingredients provide dual-action relief for patients experiencing concurrent cough and allergy symptoms.

Brand names

ACT Syrup

Other names

ambroxol hydrochloride + cetirizine hydrochloridecetirizine + ambroxol